| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &CEO | See Remarks
2 companies
Good Jennifer L serves as a President &CEO at TRVI and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 11 sells. Those positions are worth an estimated $1.4M at current prices.
Historically, Good Jennifer L's trades have earned a below-average insider score of 34/100 across 11 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -95.0%.
The biggest single holding is TRVI (~$1.4M) as President &CEO. The recent filings there lean toward selling, a net 84,808 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2025 | TRVI Trevi Therapeutics, Inc. | President &CEO | Sale+OE | 5,263 | $6.58 | $34,624.75 | -2.4% | -7.9% | +64.0% | |
| Sep 17, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 31,751 | $52.40 | $1,663,803.20 | -91.4% | +3.9% | +80.7% | |
| Sep 9, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 37,241 | $50.45 | $1,878,700.45 | -92.5% | +13.3% | +100.2% | |
| Sep 9, 2024 | TRVI Trevi Therapeutics, Inc. | President &CEO | Sale+OE | 6,059 | $3.03 | $18,371.02 | -2.8% | -14.7% | +169.9% | |
| Sep 5, 2024 | TRVI Trevi Therapeutics, Inc. | President &CEO | Sale+OE | 55,121 | $3.09 | $170,192.71 | -20.5% | -16.1% | +126.1% | |
| Aug 26, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 14,508 | $50.01 | $725,526.22 | -82.9% | +19.8% | +102.4% | |
| May 20, 2024 | TRVI Trevi Therapeutics, Inc. | President &CEO | Sale+OE | 25,037 | $2.86 | $71,575.78 | -10.5% | +4.9% | +128.6% | |
| May 10, 2024 | TRVI Trevi Therapeutics, Inc. | President &CEO | Sale+OE | 4,578 | $2.90 | $13,276.20 | -2.1% | +2.6% | +141.8% | |
| May 9, 2019 | TRVI Trevi Therapeutics, Inc. | See Remarks | Buy | 11,250 | $10.00 | $112,500.00 | +5.8% | - | - |